Merck launches US generics operation

Germany's Merck has established a US generics operation in New York -- Genpharm -- to ease access to the company on this side of the Atlantic. Robert J. Mauro, the former president of the troubled Able Laboratories in New Jersey, has been named president of Genpharm. "This will increase Merck's presence in the world's largest pharmaceutical market and will help solidify our position as the world's third-largest global generics company," said Hank Klakurka, CEO of the Merck Generics Group, a wholly owned business of Merck in Darmstadt, Germany.

- read this press release for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.